Eldridge S R, Tilbury L F, Goldsworthy T L, Butterworth B E
Chemical Industry Institute of Toxicology, Research Triangle Park, NC 27709.
Carcinogenesis. 1990 Dec;11(12):2245-51. doi: 10.1093/carcin/11.12.2245.
Different labeling methods for quantitating cell proliferation were evaluated in livers and kidneys of control and chemically treated mice and rats. The percentage of cells in S-phase (labeling indices) were compared in tissues of animals given either 5-bromo-2'-deoxyuridine (BRDU) or [3H]thymidine. These DNA precursor labels were delivered either by a single i.p. injection 2 h prior to killing the animals or via the s.c. implanted osmotic pump for 3 or 6 days. B6C3F1 mice and male F344 rats were exposed to either a peroxisome proliferator and hepatocarcinogen, Wy-14,643 (WY), in the diet at 0.1% for up to 5 days, or a non-genotoxic mouse liver and male rat kidney carcinogen, 1,4-dichlorobenzene (DCB), in corn oil by gavage for up to 5 days in mice (600 mg/kg/day) or up to 3 weeks in rats (300 mg/kg/day, 5 days per week). Labeling indices (LIs) in the liver and kidney were similar in BRDU- and [3H]thymidine-labeled mice and rats. Cell proliferation was increased in livers of both species of WY- and DCB-treated animals when compared to controls. After 4 days of chemical treatment with continuous administration of a DNA precursor label during the last 3 days of treatment, LIs in controls, DCB- and WY-treated mouse livers were 0.7, 19 and 17% for BRDU and 0.9, 15 and 13% for [3H]-thymidine respectively. Furthermore, BRDU and [3H]-thymidine labeled the same population of cells as revealed by similar patterns of cell labeling in the livers and kidneys of treated animals. The LI for BRDU- and [3H]thymidine-labeled renal proximal tubular cells was 7.7 and 8.0% respectively, in rats receiving DCB for 4 days and DNA precursor label during the last 3 days of treatment, while the LI for controls was 4.3 and 3.7% respectively. The renal proximal tubular cell LI increased to 11% in BRDU-labeled rats treated with DCB for 3 weeks. LIs in both liver and kidney were greatest in control and treated animals that received the DNA precursor label via osmotic pumps for 6 days, and least in 2 h pulse-labeled animals. However, induction of hepatic LI in treated over control animals was greatest for treated animals labeled for 3 days. These results demonstrate comparable cell labeling of cells in S-phase with either BRDU and [3H]thymidine labeling methods. BRDU presents no radioactive containment problems, and results are obtained more rapidly than [3H]thymidine.(ABSTRACT TRUNCATED AT 400 WORDS)
在对照及经化学处理的小鼠和大鼠的肝脏及肾脏中,对用于定量细胞增殖的不同标记方法进行了评估。比较了给予5-溴-2'-脱氧尿苷(BRDU)或[3H]胸苷的动物组织中处于S期的细胞百分比(标记指数)。这些DNA前体标记物通过在处死动物前2小时单次腹腔注射,或通过皮下植入渗透泵给药3天或6天。将B6C3F1小鼠和雄性F344大鼠分别暴露于饮食中0.1%的过氧化物酶体增殖剂和肝癌致癌物Wy-14,643(WY)长达5天,或通过灌胃给予玉米油中的非基因毒性小鼠肝脏及雄性大鼠肾脏致癌物1,4-二氯苯(DCB),小鼠给药长达5天(600毫克/千克/天),大鼠给药长达3周(300毫克/千克/天,每周5天)。BRDU标记和[3H]胸苷标记的小鼠和大鼠肝脏及肾脏中的标记指数相似。与对照组相比,经WY和DCB处理的两种动物的肝脏中细胞增殖均增加。在化学处理4天后,即在处理的最后3天持续给予DNA前体标记物,对照组、经DCB处理和经WY处理的小鼠肝脏中,BRDU的标记指数分别为0.7%、19%和17%,[3H]胸苷的标记指数分别为0.9%、15%和13%。此外,如经处理动物的肝脏和肾脏中相似的细胞标记模式所示,BRDU和[3H]胸苷标记的是相同的细胞群体。在接受DCB处理4天且在处理的最后3天给予DNA前体标记物的大鼠中,BRDU和[3H]胸苷标记的肾近端小管细胞的标记指数分别为7.7%和8.0%,而对照组分别为4.3%和3.7%。经DCB处理3周的BRDU标记大鼠中,肾近端小管细胞标记指数增加到11%。通过渗透泵接受DNA前体标记物6天的对照及处理动物,其肝脏和肾脏中的标记指数最高,而2小时脉冲标记的动物中标记指数最低。然而,处理组动物相对于对照组动物肝脏标记指数的诱导在标记3天的动物中最大。这些结果表明,BRDU和[3H]胸苷标记方法在S期细胞标记方面具有可比性。BRDU不存在放射性污染问题,且比[3H]胸苷能更快获得结果。(摘要截短于400字)